CORC

在结果中检索

CORC

浏览/检索结果: 共28条，第1-10条 帮助

已选(0)清除 条数/页：   排序方式：
Safety and activity of sintilimab in patients with relapsed or refractory classical Hodgkin lymphoma (ORIENT-1): a multicentre, single-arm, phase 2 trial 期刊论文
LANCET HAEMATOLOGY, 2019, 卷号: 6, 期号: 1
作者:  Zhang, Wei;  Gao, Yuhuan;  Jin, Zhengming;  Zhou, Jianfeng;  Jin, Chuan
收藏  |  浏览/下载：46/0  |  提交时间：2019/12/05
Primary breast diffuse large B-cell lymphoma in the rituximab era: therapeutic strategies and patterns of failure (vol 109, pg 3943, 2018) 期刊论文
CANCER SCIENCE, 2019, 卷号: 110, 期号: 4
作者:  Xiao, Xiubin;  Bao, Huizheng;  Wang, Ningju;  Ren, Hanyun;  Cen, Xinan
收藏  |  浏览/下载：59/0  |  提交时间：2019/12/05
Safety and activity of sintilimab in patients with relapsed or refractory classical Hodgkin lymphoma : a multicentre, single-arm, phase 2 trial 期刊论文
The Lancet Haematology, 2019, 卷号: Vol.6 No.1, 页码: e12-e19
作者:  Yuankai Shi;  Hang Su;  Yongping Song;  Wenqi Jiang;  Xiuhua Sun
收藏  |  浏览/下载：39/0  |  提交时间：2019/02/25
Evaporation rate of potassium chloride in combustion of herbaceous biomass and its calculation 期刊论文
FUEL, 2019, 卷号: 257
作者:  Li, Xiuhua;  He, Fang;  Su, Xianqiang;  Behrendt, Frank;  Gao, Zhenqiang
收藏  |  浏览/下载：3/0  |  提交时间：2019/12/11
Safety and activity of sintilimab in patients with relapsed or refractory classical Hodgkin lymphoma (ORIENT-1): a multicentre, single-arm, phase 2 trial 期刊论文
LANCET HAEMATOLOGY, 2019, 卷号: 6, 期号: 1, 页码: E12-E19
作者:  Shi, Yuankai;  Su, Hang;  Song, Yongping;  Jiang, Wenqi;  Sun, Xiuhua
收藏  |  浏览/下载：17/0  |  提交时间：2019/12/11
Lkb1 in dendritic cells restricts CD8+Foxp3+regulatory T cells expansion in vivo 期刊论文
2019, 页码: 111650
作者:  Chen Jiadi;  Zhou Yushan;  Chen Song;  Liu Maolan;  Guo Wei
收藏  |  浏览/下载：15/0  |  提交时间：2020/01/03
Primary breast diffuse large B-cell lymphoma in the rituximab era: therapeutic strategies and patterns of failure (vol 109, pg 3943, 2018) 期刊论文
2019, 卷号: 110, 期号: 4, 页码: 1503-1503
作者:  Hu, Shaoxuan;  Song, Yuqin;  Sun, Xiuhua;  Su, Liping;  Zhang, Wei
收藏  |  浏览/下载：65/0  |  提交时间：2020/01/03
Safety and activity of sintilimab in patients with relapsed or refractory classical Hodgkin lymphoma (ORIENT-1): a multicentre, single-arm, phase 2 trial 期刊论文
2019, 卷号: 6, 期号: 1, 页码: E12-E19
作者:  Shi, Yuankai;  Su, Hang;  Song, Yongping;  Jiang, Wenqi;  Sun, Xiuhua
收藏  |  浏览/下载：19/0  |  提交时间：2020/01/03
Circulating tumor DNA to predict response and resistance by anti-PD-1 therapy in Chinese relapsed/refractory classic Hodgkin lymphoma. 会议论文
Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), MAY 31-JUN 04, 2019
作者:  Su, Hang;  Song, Yongping;  Jiang, Wenqi;  Sun, Xiuhua;  Qian, Wenbin
收藏  |  浏览/下载：12/0  |  提交时间：2019/12/31
Sintilimab for relapsed/refractory classical Hodgkin's lymphoma: Extended follow-up on the multicenter, single-arm phase II ORIENT-1 study. 会议论文
Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), MAY 31-JUN 04, 2019
作者:  Su, Hang;  Song, Yongping;  Jiang, Wenqi;  Sun, Xiuhua;  Qian, Wenbin
收藏  |  浏览/下载：12/0  |  提交时间：2019/12/31

©版权所有 ©2017 CSpace - Powered by CSpace